Medicare Enrolled

Dr. Wm Honeycutt, M.D.

Optician · Maitland, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
301 N MAITLAND AVE, Maitland, FL 32751
4076475996
In practice since 2005 (20 years)
NPI: 1457340960 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Honeycutt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Honeycutt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Honeycutt

Dr. Wm Honeycutt is an optician in Maitland, FL, with 20 years in practice. Based on federal Medicare data, Dr. Honeycutt performed 25,135 Medicare services across 1,750 unique beneficiaries.

Between the years covered by Open Payments, Dr. Honeycutt received a total of $743,409 from 87 pharmaceutical and/or device companies across 2179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Honeycutt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 3% volume in FL$ $743,409 industry payments

Medicare Practice Summary

Medicare Utilization ↗
25,135
Medicare services
Top 3% in FL for optician
1,750
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,257 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit22,600$5$11
Office visit, established patient (30-39 min)1,310$91$170
New patient office visit, complex (60-74 min)257$157$316
Needle measurement of electrical activity in arm or leg muscles, complete study213$72$385
Nerve conduction, 7-8 studies126$127$1,684
Office visit, established patient, complex (40-54 min)107$131$241
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face88$121$300
Office visit, established patient (20-29 min)76$64$112
EEG, extended monitoring71$325$573
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less65$48$264
Use of electrodes during balance testing41$8$52
Nerve conduction, 5-6 studies36$88$1,263
Test to assess balance during warm and cool irrigation in both ears31$31$349
Evaluation and testing for balance with recording31$84$326
Test for abnormal eye movement using a rotating chair31$96$166
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and24$39$100
Nerve conduction, 9-10 studies15$157$2,105
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a13$32$85
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
90.5% medium
9.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$743,409
Total received (2018-2024)
Avg $106,201/year across 7 years
Top 0% in FL for optician
87
Companies
2,179
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$666,073 (89.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$61,081 (8.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,255 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$23,502
2023
$63,442
2022
$103,493
2021
$87,599
2020
$64,166
2019
$182,074
2018
$219,133

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$309,541
Genentech USA, Inc.
$90,378
Biogen, Inc.
$78,729
Horizon Therapeutics plc
$70,709
Alexion Pharmaceuticals, Inc.
$48,650
EMD Serono, Inc.
$45,239
Celgene Corporation
$27,030
ABBVIE INC.
$16,562
Allergan, Inc.
$13,746
AbbVie Inc.
$12,543
E.R. Squibb & Sons, L.L.C.
$12,473
Genentech, Inc.
$3,068
Teva Pharmaceuticals USA, Inc.
$1,969
Novartis Pharmaceuticals Corporation
$1,302
Janssen Pharmaceuticals, Inc
$1,251
Banner Life Sciences, LLC
$825
Lundbeck LLC
$636
UCB, Inc.
$583
Supernus Pharmaceuticals, Inc.
$530
PFIZER INC.
$511
Lilly USA, LLC
$496
NOVARTIS PHARMACEUTICALS CORPORATION
$414
Allergan Inc.
$342
Eisai Inc.
$313
CSL Behring
$285
Amgen Inc.
$265
ACADIA Pharmaceuticals Inc
$228
Amneal Pharmaceuticals LLC
$217
Acorda Therapeutics, Inc
$212
Kyowa Kirin, Inc.
$189
CATALYST PHARMACEUTICALS, INC.
$170
US WorldMeds, LLC
$169
SK Life Science, Inc.
$166
Neurocrine Biosciences, Inc.
$161
Mallinckrodt Hospital Products Inc.
$157
Adamas Pharmaceuticals, Inc.
$154
Biohaven Pharmaceuticals, Inc.
$151
Alnylam Pharmaceuticals Inc.
$147
Jazz Pharmaceuticals Inc.
$142
Grifols USA, LLC
$140
Neurelis, Inc.
$137
JAZZ PHARMACEUTICALS INC.
$133
MITSUBISHI TANABE PHARMA AMERICA, INC.
$132
Otsuka America Pharmaceutical, Inc.
$120
EISAI INC.
$117
TG THERAPEUTICS, INC.
$106
LivaNova USA, Inc.
$97
Avanir Pharmaceuticals, Inc.
$93
Biohaven Pharmaceutical Holding Company Ltd.
$91
Bausch Health US, LLC
$89
UPSHER-SMITH LABORATORIES LLC
$85
ARGENX US, INC.
$84
Sunovion Pharmaceuticals Inc.
$82
Greenwich Biosciences, Inc.
$80
Sumitomo Pharma America, Inc.
$79
Impax Laboratories, Inc.
$66
GE HEALTHCARE
$63
ARBOR PHARMACEUTICALS, INC.
$60
Avadel CNS Pharmaceuticals, LLC
$55
Mallinckrodt Enterprises LLC
$53
Catalyst Pharmaceuticals, Inc.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$51
Mallinckrodt LLC
$50
Zyla Life Sciences
$45
Strongbridge US INC.
$43
Harmony Biosciences LLC
$43
Xeris Pharmaceuticals, Inc.
$43
SCILEX PHARMACEUTICALS INC.
$40
Assertio Therapeutics, Inc.
$37
Sandoz Inc.
$31
Averitas Pharma Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$28
AbbVie, Inc.
$28
Currax Pharmaceuticals LLC
$26
BANNER LIFE SCIENCES, LLC
$25
Egalet US Inc
$25
Cala Health, Inc.
$21
Vanda Pharmaceuticals Inc.
$20
Avion Pharmaceuticals
$20
Organogenesis Inc.
$20
Mylan Specialty L.P.
$20
Abbott Laboratories
$19
Scilex Pharmaceuticals Inc.
$18
Medtronic, Inc.
$18
Zyla Life Sciences, Inc.
$15
Akcea Therapeutics, Inc.
$14
MDD US Operations, LLC
$14
Top 3 companies account for 64.4% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Bafiertam · Betaseron · Briviact · CALA TRIO · CONTRAVE · COPAXONE · CUTAQUIG · Cambia · DISEASE STATE · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Edarbyclor · Enspryng · Epidiolex · Evrysdi · FIRDAPSE · FYCOMPA · Fycompa · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Glatiramer Acetate · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LUMRYZ · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NEXVIAZYME · NO PRODUCT DISCUSSED · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Non-Covered Product · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ozanimod · PANZYGA · PAXLOVID · PIPELINE-MS · PLEGRIDY · PONVORY · PROCLAIM · Ponvory · Puraply · QULIPTA · QUTENZA · RADICAVA · REXULTI · RYTARY · Rebif · Reveal LINQ · SOLIRIS · SPINRAZA · SPRIX · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Vumerity · Wakix · XYREM · XYWAV · Xadago · ZEPOSIA · ZINBRYTA · ZIPSOR · ZORVOLEX · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for optician in FL.

Equivalent to $2,958 per 100 Medicare services performed
Looking for a optician in Maitland?
Compare opticians in the Maitland area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
338
Per 100K population
23.5
County median income
$77,011
Nearest hospital
ADVENTHEALTH ORLANDO
5.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Honeycutt is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (speaking/promotional, top 0%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Honeycutt experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Honeycutt performed 22,600 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Honeycutt receive payments from pharmaceutical companies?
Yes. Dr. Honeycutt received a total of $743,409 from 87 companies across 2,179 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Honeycutt's costs compare to other opticians in Maitland?
Dr. Honeycutt's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Honeycutt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →